The Market Dynamics of Generic Medicines in the Private Sector of 19 Low and Middle Income Countries between 2001 and 2011: A Descriptive Time Series Analysis-Reference-Cited by-同舟云学术

The Market Dynamics of Generic Medicines in the Private Sector of 19 Low and Middle Income Countries between 2001 and 2011: A Descriptive Time Series Analysis

Published:2013-09-30 Issue:9 Volume:8 Page:e74399
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kaplan Warren A.,Wirtz Veronika J.,Stephens Peter

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. A decade of generic pharmaceutical policies in Brazil;AC Gomes Barra;J. Generic Med,2011

2. Medicine prices in Thailand: A result of no medicine pricing policy;C Sooksriwong;Southern Med Rev,2009

3. Kanavos P (2008) Generic policies: rhetoric vs. reality. European Observatory on Health Systems and Policies. Available: http://www.euro.who.int/_data/assets/pdf_file/0015/80340/EuroObserver_Summer_2008.pdf. Accessed 13 Dec 2012.

4. Sheppard A (2011) Generic Medicines: Essential contributors to the long-term health of society. IMS Health, London. Available: http://www.imshealth.com/imshealth/Global/Content/Document/Market_Measurement_TL/Generic_Medicines_GA.pdf. Accessed 4 Nov 2012.

5. Generic Medicine Pricing Policies in Europe: Current Status and Impact;P Dylst;Pharmaceuticals,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patent and Marketing Exclusivities 101 for Drug Developers;Recent Patents on Biotechnology;2023-09

2. Willingness to pay brand premiums for generic medicines in Kenya: A bidding game experiment;The International Journal of Health Planning and Management;2023-06-19

3. THE ALIMENTARY AND METABOLISM MARKET IN ROMANIA 1998 - 2018. ANALYSIS AND EVOLUTION;FARMACIA;2021-08-23

4. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal;Global Heart;2021-05-18

5. Immense price variation of branded generic medicines in low-income countries: The need for an inclusive price control policy;Research in Social and Administrative Pharmacy;2020-09